In:
Problems of Endocrinology, Endocrinology Research Centre, Vol. 58, No. 1 ( 2012-02-15), p. 3-8
Abstract:
The patients in the active phase of endogenous hypercorticism not infrequently present with hypercoagulation syndrome characterized by abnormal blood clotting in conjunction with slowed fibrinolysis, elevated fibrinogen and D-dimer concentrations. In addition, such patients exhibit endotheliosis manifest as a rise in the PAI-1 and Willebrand factor levels. The remission of the Cushing's disease (CD) is associated with a higher fibrinogen, thrombomodulin, endothelin-1, and D-dimer levels compared with CD patients in the active phase of this disease and healthy subjects (control). This suggests the continuing progression of endotheliosis, enhanced thrombogenicity, and the increased risk of cardiovascular complications.
Type of Medium:
Online Resource
ISSN:
2308-1430
,
0375-9660
DOI:
10.14341/probl2012581
DOI:
10.14341/probl20125813-8
Language:
Unknown
Publisher:
Endocrinology Research Centre
Publication Date:
2012
Permalink